Recombinant activated factor VII for treatment of enoxaparin-induced bleeding

Mayo Clin Proc. 2004 Jun;79(6):827. doi: 10.4065/79.6.827.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Enoxaparin / adverse effects*
  • Factor VIIa / therapeutic use*
  • Fibrinolytic Agents / adverse effects*
  • Hemorrhage / chemically induced
  • Hemorrhage / drug therapy*
  • Humans
  • Male
  • Recombinant Proteins / therapeutic use

Substances

  • Enoxaparin
  • Fibrinolytic Agents
  • Recombinant Proteins
  • Factor VIIa